{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:17:04Z","timestamp":1790414224965,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>The purpose of this study was to evaluate the utility of baseline interferon (IFN)-inducible gene expression as a prognostic biomarker for Anti-tubercular therapy (ATT) response in patients with undetermined cause of uveitis who tested positive for QuantiFERON-TB Gold (QFT-positive uveitis).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This prospective cohort study included 17 QFT-positive uveitis patients at a tertiary uveitis center in Indonesia. Baseline and week 2 peripheral blood transcripts were evaluated through real time-quantitative polymerase chain reaction to assess the expression of 10 IFN-inducible genes (IRF7, IFIT2, STAT1, IL1B, MyD88, TLR8, FCGR1B, GBP1, UBE2L6, and SERPING1). Patients were stratified into clusters based on gene expression patterns. The primary outcome was complete resolution of uveitis at 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Hierarchical clustering revealed two distinct groups. Patients with higher baseline expression of IFN genes (Cluster 2) were more likely to achieve complete uveitis resolution after ATT compared to those with lower expression levels (Cluster 1) (80% vs. 43%). Using a previously established IFN gene signature score (IGSS) cutoff (\u22655.61), 82% of high-scoring patients showed complete resolution, compared to only 33% in the low-scoring group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.046). However, week 2 gene expression changes did not correlate with treatment response, indicating limited utility in monitoring disease activity or predicting long-term outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Baseline, but not week 2, peripheral blood IFN-inducible gene expression may serve as a prognostic biomarker for stratifying QFT-positive uveitis patients through prediction of their response to treatment. Patients with higher baseline IGSS are more likely to require ATT to achieve uveitis resolution at 6-month follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo-d-25-00029","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T01:00:10Z","timestamp":1749085210000},"page":"259-269","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Can interferon-inducible gene expression guide treatment? A prospective study in QuantiFERON-positive uveitis with undetermined cause"],"prefix":"10.4103","volume":"15","author":[{"given":"Rina La Distia","family":"Nora","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Riasanti","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"},{"name":"Indonesia Infectious Disease and Immunology Research Center, Indonesia Medical Education and Research Institute, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna","family":"Sitompul","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukman","family":"Edwar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Made","family":"Susiyanti","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Aziza","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhwanuliman","family":"Putera","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Valentina","family":"Wibawa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulifna Alfiya","family":"Sifyana","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zakiy","family":"Waliyuddin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ethelind","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Indonesia \u2013 Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beti Ernawati","family":"Dewi","sequence":"additional","affiliation":[{"name":"Indonesia Infectious Disease and Immunology Research Center, Indonesia Medical Education and Research Institute, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia"},{"name":"Department of Microbiology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heri","family":"Wibowo","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/eye.2017.231","article-title":"Tuberculosis and other causes of uveitis in Indonesia","volume":"32","author":"La Distia Nora","year":"2018","journal-title":"Eye (Lond)"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.3109\/09273948.2016.1161804","article-title":"Patterns of uveitis and scleritis in Nepal:A tertiary referral center study","volume":"25","author":"Manandhar","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.3109\/09273948.2015.1133839","article-title":"Epidemiology of uveitis in a tertiary eye center in Myanmar","volume":"25","author":"Win","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"100301","DOI":"10.1016\/j.lansea.2023.100301","article-title":"Ending TB in South-East Asia:Flagship priority and response transformation","volume":"18","author":"Bhatia","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"104","DOI":"10.22435\/hsji.v12i2.5467","article-title":"Spatial variation of tuberculosis risk in Indonesia 2010\u20132019","volume":"12","author":"Veridona","year":"2021","journal-title":"Health Science Journal of Indonesia"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4103\/ijo.IJO_1451_20","article-title":"Ocular tuberculosis:Where are we today?","volume":"68","author":"Testi","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2019.11.009","article-title":"Prevalence of positive QuantiFERON-TB gold in-tube test in uveitis and its clinical implications in a country nonendemic for tuberculosis","volume":"211","author":"Groen-Hakan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajo.2013.11.013","article-title":"Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis","volume":"157","author":"La Distia Nora","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"e0206073","DOI":"10.1371\/journal.pone.0206073","article-title":"Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis:A tool to stratify a high versus low risk of active tuberculosis?","volume":"13","author":"La Distia Nora","year":"2018","journal-title":"PLoS One"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fnmol.2019.00314","article-title":"Inflammatory role of TLR-MyD88 signaling in multiple sclerosis","volume":"12","author":"Zheng","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12703\/P6-97","article-title":"MyD88:A central player in innate immune signaling","volume":"6","author":"Deguine","year":"2014","journal-title":"F1000Prime Rep"},{"key":"R13-20250618","article-title":"IRF7 from the black flying fox induces a STAT1-independent ISG response in unstimulated cell lines that protects against diverse RNA viruses","author":"Cruz-Rivera","year":"2024","journal-title":"bioRxiv [Preprint]"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"e100926","DOI":"10.15252\/embj.2018100926","article-title":"Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis","volume":"38","author":"Fisch","year":"2019","journal-title":"EMBO J"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tube.2013.05.002","article-title":"Pathways of IL-1\u03b2 secretion by macrophages infected with clinical Mycobacterium tuberculosis strains","volume":"93","author":"Krishnan","year":"2013","journal-title":"Tuberculosis (Edinb)"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"e0313421","DOI":"10.1128\/mBio.03134-21","article-title":"Advances on the role and applications of interleukin-1 in tuberculosis","volume":"12","author":"Silv\u00e9rio","year":"2021","journal-title":"mBio"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1016\/j.cell.2023.11.002","article-title":"Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis","volume":"186","author":"Kotov","year":"2023","journal-title":"Cell"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"104173","DOI":"10.1016\/j.ebiom.2022.104173","article-title":"Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment","volume":"82","author":"van Doorn","year":"2022","journal-title":"EBioMedicine"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R22-20250618","first-page":"9","article-title":"PAST:Paleontological statistics software package for education and data analysis","volume":"4","author":"Hammer","year":"2021","journal-title":"Paleontol Electronica"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ni.2605","article-title":"Targeting of a natural killer cell receptor family by a viral immunoevasin","volume":"14","author":"Berry","year":"2013","journal-title":"Nat Immunol"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-020-19412-6","article-title":"Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis","volume":"11","author":"Moreira-Teixeira","year":"2020","journal-title":"Nat Commun"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"101547","DOI":"10.1016\/j.smim.2021.101547","article-title":"Cellular and molecular diversity in Sjogren's syndrome salivary glands:Towards a better definition of disease subsets","volume":"58","author":"Pontarini","year":"2021","journal-title":"Semin Immunol"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1462-5822.2012.01827.x","article-title":"Identification of a novel role of ESAT-6-dependent miR-155 induction during infection of macrophages with Mycobacterium tuberculosis","volume":"14","author":"Kumar","year":"2012","journal-title":"Cell Microbiol"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"e45839","DOI":"10.1371\/journal.pone.0045839","article-title":"Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis","volume":"7","author":"Ottenhoff","year":"2012","journal-title":"PLoS One"},{"key":"R29-20250618","doi-asserted-by":"crossref","first-page":"e1000361","DOI":"10.1371\/journal.pbio.1000361","article-title":"Functional crosstalk between type I and II interferon through the regulated expression of STAT1","volume":"8","author":"Gough","year":"2010","journal-title":"PLoS Biol"},{"key":"R30-20250618","doi-asserted-by":"crossref","first-page":"17609","DOI":"10.1073\/pnas.1209724109","article-title":"Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases","volume":"109","author":"Hall","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-20250618","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3389\/fimmu.2017.01633","article-title":"Type I interferons in the pathogenesis of tuberculosis:Molecular drivers and immunological consequences","volume":"8","author":"Donovan","year":"2017","journal-title":"Front Immunol"},{"key":"R32-20250618","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/clinpract12050082","article-title":"Role of interferons in Mycobacterium tuberculosis infection","volume":"12","author":"Shanmuganathan","year":"2022","journal-title":"Clin Pract"},{"key":"R33-20250618","doi-asserted-by":"crossref","first-page":"e244769","DOI":"10.1001\/jamanetworkopen.2024.4769","article-title":"Comparison of tuberculin skin testing and interferon-\u03b3 release assays in predicting tuberculosis disease","volume":"7","author":"Ayers","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R34-20250618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.00664-18","article-title":"Depressed gamma interferon responses and treatment outcomes in tuberculosis patients:A prospective cohort study","volume":"56","author":"Feng","year":"2018","journal-title":"Journal of Clinical Microbiology"},{"key":"R35-20250618","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/jpm9040046","article-title":"Using the immunophenotype to predict response to biologic drugs in rheumatoid arthritis","volume":"9","author":"Mulhearn","year":"2019","journal-title":"J Pers Med"},{"key":"R36-20250618","doi-asserted-by":"crossref","first-page":"850015","DOI":"10.3389\/fimmu.2022.850015","article-title":"Discovery of novel circulating immune complexes in lupus nephritis using immunoproteomics","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"R37-20250618","first-page":"i32","article-title":"Systemic lupus erythematosus biomarkers:The challenging quest","volume":"56","author":"Arriens","year":"2017","journal-title":"Rheumatology"},{"key":"R38-20250618","doi-asserted-by":"crossref","first-page":"e37103","DOI":"10.1016\/j.heliyon.2024.e37103","article-title":"Increased serum interferon activity in sarcoidosis compared to that in tuberculosis:Implication for diagnosis?","volume":"10","author":"Schrijver","year":"2024","journal-title":"Heliyon"},{"key":"R39-20250618","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4046\/trd.2017.80.1.27","article-title":"Duration of pulmonary tuberculosis infectiousness under adequate therapy, as assessed using induced sputum samples","volume":"80","author":"Ko","year":"2017","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"R43-20250618","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/s41467-018-04579-w","article-title":"A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection","volume":"9","author":"Singhania","year":"2018","journal-title":"Nat Commun"},{"key":"R44-20250618","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.0954-6820.1983.tb03748.x","article-title":"Altered prednisolone pharmacokinetics in patients treated with rifampicin","volume":"213","author":"Bergrem","year":"1983","journal-title":"Acta Med Scand"},{"key":"R45-20250618","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.1976.03270180034016","article-title":"Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function","volume":"236","author":"Buffington","year":"1976","journal-title":"JAMA"},{"key":"R46-20250618","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s12276-023-00964-8","article-title":"Corticosteroids reduce pathologic interferon responses by downregulating STAT1 in patients with high-risk COVID-19","volume":"55","author":"Jeong","year":"2023","journal-title":"Exp Mol Med"},{"key":"R47-20250618","doi-asserted-by":"crossref","first-page":"1199482","DOI":"10.3389\/fimmu.2023.1199482","article-title":"Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections","volume":"14","author":"Ivanov","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"R48-20250618","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.38628","article-title":"Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures","volume":"66","author":"Chiche","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R49-20250618","first-page":"1","article-title":"Ocular Tuberculosis Diagnosis Through Biomarkers:Clinical Relevance of Serum C1Q and Whole Blood Interferon Gene Signature Score","author":"La Distia Nora","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"R50-20250618","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12886-017-0597-x","article-title":"What does IGRA testing add to the diagnosis of ocular tuberculosis?A Bayesian latent class analysis","volume":"17","author":"Agrawal","year":"2017","journal-title":"BMC Ophthalmol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-25-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:24:35Z","timestamp":1787837075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-25-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-25-00029","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2025-02-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}